Glen Clova Scientific (private company)

See something wrong or missing? Let us know
Offices:Dundee
Business model:B2B

Glen Clova Scientific - GCS - is a spin out from the University of Dundee developing drugs for chronic inflammatory and autoimmune disorders.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 5.08M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Glen Clova Scientific

Name Criteria
Norway Curida
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Denmark Octarine Bio
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
France Pharmedigroup
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Italy Harg
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Finland Brinter
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Germany CEVEC Pharmaceuticals
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Germany apriwell
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Oncorena
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Italy IAMA Therapeutics
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Netherlands InnoSIGN
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Top